BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

European Medicines Agency (Ema)

Headquarters: Amsterdam, Netherlands
Year Founded: 1995
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Feb 3, 2025
Guest Commentary

Rebuilding trust in FDA through labeling clarity and transparency

Regulatory agency must be proactive in fighting the surge in skepticism about the drugs and vaccines it regulates
BioCentury | Oct 18, 2024
Management Tracks

Hoess succeeds Crawford at ViaNautis

Plus: Korenberg now CFO of Palvella and updates from Moffitt and CHMP
BioCentury | Sep 19, 2024
Management Tracks

EMA names Sepodes CHMP chair, Bell leaving Valo as CEO, and more

Plus: Autolus hires Matthias Will as CDO, and updates from HotSpot, Prilenia, Frazier, BIA and BioCentriq
BioCentury | Jan 25, 2024
Data Byte

EMA’s CHMP recommended fewer expedited approvals in 2023

The year also hit a new record for applications withdrawn during review
BioCentury | Nov 1, 2023
Regulation

FDA illuminates the single trial path

How one trial plus confirmatory evidence can add up to approval
BioCentury | Jun 19, 2023
Regulation

EMA’s Cooke, what’s next for IPSCs, and Leerink is back 

Plus: a conversation with Forbion, and why Senate Democrats are holding up confirmation of a new NIH director
BioCentury | Jun 15, 2023
Politics, Policy & Law

Next up for EMA head Emer Cooke: pharma legislation

Having steered Europe’s regulatory agency through the pandemic, her next mark will be how she tackles the upcoming pharma legislation 
BioCentury | Mar 2, 2023
Politics, Policy & Law

Europe’s shrinking regulatory protections

Leaked EU pharma legislation proposes to reduce regulatory protections for NMEs, orphan drugs
BioCentury | Mar 2, 2023
Politics, Policy & Law

EC to propose AMR vouchers, cutting red tape

Leaked draft pharma legislation seeks to streamline European drug oversight, incentivize antimicrobials
BioCentury | Dec 9, 2022
Finance

Dec. 8 Quick Takes: ADC play Dantari debuts with $47M led by Westlake 

Plus: Sanofi ends SHP2 deal with Revolution and updates from Novartis, Daiichi, Takeda, Autolus, C-PATH and more 
Items per page:
1 - 10 of 671